TELA Bio (TELA) Free Cash Flow (QoQ) (2019 - 2026)
Powered by 
Analysis
TELA Bio (TELA) Free Cash Flow (QoQ) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn |
| 10 | TELA Bio | 48.87 Mn | 18.44 Mn | 13.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.38% |
| Mar 31, 2026 | -127.55% |
| Dec 31, 2025 | 16.34% |
| Sep 30, 2025 | 26.05% |
| Jun 30, 2025 | 17.81% |
| Mar 31, 2025 | -25.17% |
| Dec 31, 2024 | 14.39% |
| Sep 30, 2024 | 17.20% |
| Jun 30, 2024 | 25.14% |
| Mar 31, 2024 | -30.49% |
| Dec 31, 2023 | -58.49% |
| Sep 30, 2023 | 37.82% |
| Jun 30, 2023 | 2.29% |
| Mar 31, 2023 | -5.98% |
| Dec 31, 2022 | -38.92% |
| Sep 30, 2022 | 33.21% |
| Jun 30, 2022 | -10.40% |
| Mar 31, 2022 | -9.00% |
| Dec 31, 2021 | -42.88% |
| Sep 30, 2021 | -22.09% |